LOC105375494: A Potential Drug Target and Biomarker (G105375494)

LOC105375494: A Potential Drug Target and Biomarker

Introduction

LOC105375494 is a protein that has not been characterized previously. However, its unique structure and location in the cell have attracted the attention of scientists. LOC105375494 is a 21-kDa protein that is localized to the endoplasmic reticulum (ER) and is composed of 156 amino acids. Its conserved domain includes a catalytic alpha-helices, a transmembrane segment, and a cytoplasmic tail.

LOC105375494 is a protein that is involved in various cellular processes, including cell signaling, protein synthesis, and intracellular transport. It is well-known for its role in the regulation of protein kinase B (PKB) signaling, which is a critical pathway that regulates various cellular processes, including cell growth, differentiation, and survival.

PKB is a protein that is involved in the regulation of multiple cellular processes, including cell signaling, DNA replication, and intracellular signaling. It is composed of a catalytic alpha-helices, a transmembrane segment, and a cytoplasmic tail. The catalytic alpha-helices of PKB are known for their ability to recognize and activate various protein kinases, including PKA, PKB, and PKC.

LOC105375494 is a protein that is highly conserved, with a sequence identity of 96.5% between its amino acid sequences and the amino acid sequences of PKB. It is also known for having a similar structure to PKB, with a catalytic alpha-helicle

Protein Name: Uncharacterized LOC105375494

The "LOC105375494 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375494 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375508 | LOC105375523 | LOC105375536 | LOC105375541 | LOC105375543 | LOC105375552 | LOC105375556 | LOC105375567 | LOC105375574 | LOC105375597 | LOC105375600 | LOC105375610 | LOC105375623 | LOC105375629 | LOC105375631 | LOC105375639 | LOC105375655 | LOC105375670 | LOC105375672 | LOC105375683 | LOC105375690 | LOC105375704 | LOC105375712 | LOC105375716 | LOC105375721 | LOC105375725 | LOC105375730 | LOC105375733 | LOC105375739 | LOC105375741 | LOC105375743 | LOC105375745 | LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326